Now double risks on Orpea’s reliable business model
25/03/20 -"Orpea once again announced in line and supportive FY results. We remain confident in its solid fundamentals. However, we worry about the extent the current Coronavirus pandemic could affect the ..."
Pages
53
Language
English
Published on
25/03/20
You may also be interested by these reports :
15/10/26
Dräger’s Q3 26 prelims were soft, with sales and EBIT 1.3% and 8.4% below our estimates. EBIT included €20.1m of customs refunds; excluding these, ...
13/10/26
Demant reported robust preliminary Q3 sales figures, driven by strong demand for its newly launched hearing aids. The 2026 guidance has been revised ...
09/10/26
Our target price has been revised downwards due to updated estimates following management’s decision to lower the upper end of its topline guidance ...
08/10/26
Our target price has increased due to a higher NAV and DCF, along with a 20% premium applied to our peer-based valuation metrics, excluding dividend ...